Cite
MLA Citation
David Propper et al.. “Phase II study of TP300 in patients with advanced gastric or gastro-oesophageal junction adenocarcinoma.” BMC cancer, vol. 16, no. 1, 2016, pp. 1–7. http://access.bl.uk/ark:/81055/vdc_100080874310.0x0001ec